Granules, NIPER-Mohali ink pact to establish centre of excellence in innovative, sustainable pharma development

October 16, 2023 08:50 pm | Updated 08:50 pm IST - HYDERABAD

Granules India CMD Krishna Prasad Chigurupati with NIPER director Dulal Panda at the MoU signing event in Mohali.

Granules India CMD Krishna Prasad Chigurupati with NIPER director Dulal Panda at the MoU signing event in Mohali.

Drugmaker Granules India and National Institute of Pharmaceutical Education and Research (NIPER) in Mohali, Chandigarh, have signed an MoU to establish Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).

Work in crucial areas such as exploring plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods in producing directly compressible crystals, promotion of solvent-free pharmaceutical processes and the development of resource-efficient and energy-efficient pharmaceutical products will be the focus of the proposed centre, Granules said in a release on the MoU signed recently.

Granules India has committed support for the establishment and operation of the research centre. The partnership includes establishment of laboratories and research facilities on the NIPER campus to facilitate research for development of sustainable and innovation driven pharmaceuticals. The collaboration will feature joint research initiatives, ensuring a seamless flow of knowledge between the industry and academia, the company said.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.